Ioversol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
1-N,3-N-bis(2,3-dihydroxypropyl)-5-[2-hydroxy-N-(2-hydroxyethyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Identifiers | |
| ATC code | V08AB07 (WHO) |
| PubChem | CID 3741 |
| ChemSpider |
3610 |
| UNII |
N3RIB7X24K |
| KEGG |
D01555 |
| ChEMBL |
CHEMBL1200614 |
| Chemical data | |
| Formula | C18H24I3N3O9 |
| Molar mass | 807.11127 |
| |
| |
| | |
Ioversol (INN) is an organoiodine compound that used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
